This guidance provides recommendations to clinical investigators and sponsors regarding the inclusion of patients who have not received available therapy for their cancer in clinical trials of drugs and biological products for the treatment of cancer in the non-curative setting.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5emAPHd
No comments:
Post a Comment